RxDoctor Payments DataLook up a doctor →

Michael Flores

Physician Assistant · Lynwood, CANPI 1427503515

Payments from drug & device makers

$97,408in general payments, 2019–2025

Across 1,268 payments — averaging $76.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Esperion Therapeutics, Inc.$33K
  • Amgen$25K
  • Dexcom, Inc.$5K
  • Regeneron Healthcare Solutions, Inc.$4K
  • Madrigal Pharmaceuticals$3K
  • AstraZeneca$3K
  • plus $24K from 54 others

What the payments were for

  • Consulting fees$2,0612%
  • Speaking & faculty fees$54,49956%
  • Travel & lodging$3,0813%
  • Food & beverage$37,43238%
  • Education$3360%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Esperion Therapeutics, Inc.138$33,182
Amgen(2 entities)163$24,707
Dexcom, Inc.23$5,020
Regeneron Healthcare Solutions, Inc.16$3,858
Madrigal Pharmaceuticals49$3,444
AstraZeneca(2 entities)64$3,308
AbbVie162$3,288
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC71$1,563
Medtronic10$1,555
Novo Nordisk55$1,502
Johnson & Johnson(2 entities)39$1,381
Lilly USA, LLC48$1,223
Sanofi29$1,160
Pfizer51$990
Biohaven Pharmaceuticals, Inc.8$947
Ardelyx, Inc.20$905
Bayer21$882
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)23$787
Lundbeck LLC28$780
Merck32$743
Boehringer Ingelheim20$580
Paratek Pharmaceuticals, Inc.21$416
Lexicon Pharmaceuticals, Inc.14$377
Novartis24$371
Otsuka America Pharmaceutical, Inc.11$360
Antares Pharma, Inc.8$312
Astellas Pharma US Inc7$280
Shield Therapeutics Inc10$278
Nestle Healthcare Nutrition Inc.3$257
Verona Pharma, Inc.11$243
Halozyme Inc8$233
Amarin Pharma, Inc.9$232
GSK8$223
Corium, LLC4$190
Idorsia Pharmaceuticals US Inc3$162
E.r. Squibb & Sons, L.L.C.3$152
Aimmune Therapeutics, Inc.2$149
Phathom Pharmaceuticals, Inc.1$125
Ionis Pharmaceuticals, Inc.2$124
Sanofi-aventis U.S. LLC4$124
Organon4$117
Ironwood Pharmaceuticals, Inc5$115
Smith+Nephew6$102
Gilead4$91
Sumitomo Pharma America, Inc.3$88
Takeda Pharmaceuticals U.S.A., Inc.3$73
Vertex2$67
Dermira, Inc.2$45
Redhill Biopharma Inc.2$34
Sunovion Pharmaceuticals Inc.1$24
Exeltis, USA Inc.1$23
Chiesi USA, Inc.1$23
Abbott1$23
Genentech USA, Inc.1$20
Amryt Pharma Holdings Ltd1$20
Axsome Therapeutics, Inc.1$20
Theracosbio, LLC1$18
Seqirus USA Inc1$17
Mannkind Corporation1$17
Eisai Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$97,408 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban560$347,397
Repatha SureclickEvolocumab304$169,911
FarxigaDapagliflozin Propanediol271$166,027
JardianceEmpagliflozin208$146,861
KerendiaFinerenone200$136,867
NexlizetBempedoic Acid/Ezetimibe321$134,675
XifaxanRifaximin51$117,462
JanuviaSitagliptin Phosphate150$115,394
OzempicSemaglutide103$99,970
DapagliflozinDapagliflozin Propanediol150$89,337
OtezlaApremilast18$83,221
Diclofenac Sodium116$80,687
ProliaDenosumab50$79,525
UbrelvyUbrogepant76$78,392
ZenpepLipase/Protease/Amylase13$65,010

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto, Procrit$1,381$382,430623 claims
AstraZenecaFarxiga, Lokelma, Breztri Aerosphere$3,308$251,149381 claims
Esperion Therapeutics, Inc.Nexlizet, Nexletol$33,182$189,650446 claims
MerckJanuvia, Verquvo, Janumet$743$174,187227 claims
AmgenOtezla, Prolia$24,707$162,74668 claims
Boehringer IngelheimJardiance, Tradjenta$580$156,566225 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance$1,563$146,530102 claims
BayerKerendia$882$136,867200 claims
Novo NordiskOzempic, Rybelsus$1,502$134,445135 claims
AbbVieUbrelvy, Linzess, Qulipta$3,288$121,292128 claims
Lilly USA, LLCMounjaro, Trulicity$1,223$78,46371 claims
Aimmune Therapeutics, Inc.Zenpep$149$65,01013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Lynwood

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →